sofosbuvir has been researched along with Respiratory Syndrome, Acute, Severe in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Becerra, A; Campillo-Balderas, JA; Jácome, R; Lazcano, A; Ponce de León, S | 1 |
1 other study(ies) available for sofosbuvir and Respiratory Syndrome, Acute, Severe
Article | Year |
---|---|
Sofosbuvir as a potential alternative to treat the SARS-CoV-2 epidemic.
Topics: Antiviral Agents; Base Sequence; Betacoronavirus; Catalytic Domain; Computer Simulation; Coronavirus Infections; Coronavirus RNA-Dependent RNA Polymerase; COVID-19; Humans; Middle East Respiratory Syndrome Coronavirus; Pandemics; Pneumonia, Viral; Protein Binding; Protein Structure, Tertiary; RNA-Dependent RNA Polymerase; SARS-CoV-2; Severe Acute Respiratory Syndrome; Severe acute respiratory syndrome-related coronavirus; Sofosbuvir; Viral Nonstructural Proteins | 2020 |